Navigation Links
Diatos Announces Positive Clinical Results for its DTS-201,Doxorubicin Prodrug Program

the tumor site, avoiding systemic side effects. DTS-301 is in Phase II clinical studies and was in-licensed from Protherics PLC (LSE: PTI / NASDAQ: PTIL).

-- DTS-201, a doxorubicin prodrug, increases the concentration of doxorubicin, a widely used cancer drug, at the tumor site by means of a reactivation mechanism specific to the tumor environment. DTS-201 has completed Phase I clinical studies in Belgium and France in Q2-07. Exclusive European rights for DTS-201 were in-licensed from Medarex Inc.

-- DTS-108 is a prodrug of SN-38, the active metabolite of the widely-used cancer drug irinotecan, and is based on Diatos' Vectocell(R) technology. DTS-108 aims to increase the efficacy of SN-38 while reducing the toxic effects of irinotecan. DTS-108 is in preclinical development.

For more information on Diatos, please visit www.diatos.com.

The Diatos logo and Vectocell(R) are registered trademarks of Diatos SA.

Contact

Diatos SA
General enquiries
Dr John Tchelingerian, PhD, President & CEO
c/o Virginie Leplat
Director of Human Resources & Administration
Tel.: +33 (0)1 53 80 93 80
vleplat@diatos.com
or
c/o Guillaume Dussert, Associate BD & Marketing Manager
Tel.: +33-(0)1 53 80 93 83
gdussert@diatos.com
or
Medical enquiries
Dr Jamal Gasmi, MD, MSc
Chief Medical Officer
Head of Clinical Development & Regulatory Affairs
Tel.: +33 (0)1 53 80 93 53
jgasmi@diatos.com
or
Press contacts
Northbank Communications
Justine Lamond, +44 (0)20 7268 3242





Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:11/25/2009)...e/--RegadoBiosciences,aprivatelyheldcompanyleading...ntrolagents,announcedthatDavidMazzo,PhD,CEOandPres...ealthCareConferenceattheNewYorkPalaceHotelinNewYor...T)onTuesday,December1andwillincludeanoverviewofthe...rogram,theanticoagulantsystem,REG1.Thehealthcarein...
(Date:11/25/2009)...re/--SwissrayInternational,Inc.aleadingmanufacture...dtodaythatitsoperationshavebeenacquiredbyaprivateS...y,smedicalimagingbrand.Theacquisitionincludedallas...ventory.After25yearsofsuccessandgrowthSwissrayisno...entswithstableandsteadygrowth. ,, "Swissrayhasl...
(Date:11/25/2009)...linker.comannouncesthatanewmarketresearchreportisa...ery-USMarketTrends&Analysis http://www.report...Market-Trends--Analysis.html ,, TheUSintranasa...euticapplicationsfromthedeliveryofconventionalloca...cdrugs.Thefutureofthetechnologyhingesontotheeffect...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5The Sloane Clinic pioneers Ultherapy in Singapore 54003 1The Sloane Clinic pioneers Ultherapy in Singapore 54003 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 3Novel mechanism revealed for increasing recombinant protein yield in tobacco 9522 1Extinction runs in the family 9520 1Extinction runs in the family 9520 2
...., April 19, 2007 /PRNewswire-FirstCall/ --,Allos ...sion of the,European Communities, with a favorable...ducts of the European Medicines Agency (EMEA),has...novel,antifolate PDX (pralatrexate) for the treatm...TCL). In July 2006, the U.S. Food and,Drug Adminis...
...l 16, 2007 /PRNewswire/ -- Sirion Therapeutics,In...y, announced,today that it has received orphan dru...n (FDA) for its anti-viral therapy,ganciclovir, f...product is currently marketed by Laboratoires Thea...on licensed the rights to,Virgan(R) for the United...
Other Medicine Technology:Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2
(Date:11/27/2009)... XenaCare Holdings has announced that it has ...ion, one of the largest nonprofit organizations de...ucation. , Delray Beach, ... Inc. (OTCBB: XCHO), a company specializing in the...lthcare products, has announced today that is has ...
(Date:11/27/2009)... Multi-purpose bilingual coloring books desig... the business community to educate - inform parent... Safety issues to Dinosuars to ABC,S and a host of...uis, MO (PRWEB) November 27, 2009 -- Today’s... to keep them busy any hour of the day, but one of...
(Date:11/26/2009)...rs, the number of Americans living with diabetes w... 2009 to 44.1 million in 2034. Over the same perio... from $113 billion to $336 billion, even with no i...based at the University of Chicago report in the D...f those with diabetes covered by Medicare will ris...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center,...s , is one of a growing number of physicians who a...sites to connect with individuals who are interest...id obesity. Dr. Kim is utilizing Facebook to share... practice with the community. , ...
(Date:11/25/2009)...o.,Nov.25/PRNewswire/--TheBartleHallConventionCent...iniconDec.9-10,whenKansasCityhoststhelatestinaseri...hisfreecliniceventhasthepotentialtobethebiggestone...andbeheldonweekdaysinsteadofoveraweekend,"SheriWoo...andpresidentoftheNationalAssociationofFreeClinics(...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
... Licensed Chiropractor Dr.... , Newburgh, NY (Vocus) O...he midst of one of the most stressful times in its...ribute to increased stress. And with growing stre...
...RIS, October 7 Bull - expert in open,flexible and...s and one of,Europe,s leading players in the IT in...ement for the acquisition of its Medicaid solution...and consulting services company. These operations ...
... LearnCDHC, a Web-based re...t consumer-directed healthcare (CDHC) options incl...ursement Accounts (HRAs) and Flexible Spending Acc...all to midsize business model. , ...
...SHINGTON, Oct. 6 The United States has,intervened...hat they,submitted false claims to Medicare arisin...sham durable medical equipment (DME) suppliers, th...en Gate Ancillary LLC, Beverly Enterprises Inc., C...
...ATTLE, Oct. 6 A special supplement of the Oct. 15...nes for low- and,middle-income countries to implem... most common disease among women worldwide., "Gui... system of resource allocation -- based on countri...
... LegalView recently posted...rtal regarding the potentially serious side effect...nhibitors. Among the drug,s potential side effects...ctober 6, 2008 -- LegalView, the number one resour...
Other Medicine News:Health News:Prescriptions for Stress 2Health News:Prescriptions for Stress 3Health News:Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix 2Health News:Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix 3Health News: LearnCDHC Bridges Education Gap on Consumer Directed Healthcare : Interactive Web resource engages and educates consumers about consumer-directed healthcare 2Health News: LearnCDHC Bridges Education Gap on Consumer Directed Healthcare : Interactive Web resource engages and educates consumers about consumer-directed healthcare 3Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 3Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3
...he Ultralign spinal orthosis. This is an extremely... effective support on 80% of all post-operative pa...gid inserts and weighing 60% less than comparable ...r, easily configured, lighter device without sacr...
Ultra Cervical Collar
Serpentine Cervical Collar
'Marlin' Cervical Orthosis
Medicine Products: